Phospholipidomics in Clinical Trials for Brain Disorders: Advancing our Understanding and Therapeutic Potentials

Mol Neurobiol. 2024 Jun;61(6):3272-3295. doi: 10.1007/s12035-023-03793-y. Epub 2023 Nov 20.

Abstract

Phospholipidomics is a specialized branch of lipidomics that focuses on the characterization and quantification of phospholipids. By using sensitive analytical techniques, phospholipidomics enables researchers to better understand the metabolism and activities of phospholipids in brain disorders such as Alzheimer's and Parkinson's diseases. In the brain, identifying specific phospholipid biomarkers can offer valuable insights into the underlying molecular features and biochemistry of these diseases through a variety of sensitive analytical techniques. Phospholipidomics has emerged as a promising tool in clinical studies, with immense potential to advance our knowledge of neurological diseases and enhance diagnosis and treatment options for patients. In the present review paper, we discussed numerous applications of phospholipidomics tools in clinical studies, with a particular focus on the neurological field. By exploring phospholipids' functions in neurological diseases and the potential of phospholipidomics in clinical research, we provided valuable insights that could aid researchers and clinicians in harnessing the full prospective of this innovative practice and improve patient outcomes by providing more potent treatments for neurological diseases.

Keywords: Analytical approaches; Brain lipid; Clinical trials; Lipid biomarkers; Lipid profiling; Lipidomics.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Brain Diseases* / diagnosis
  • Brain Diseases* / metabolism
  • Brain Diseases* / therapy
  • Clinical Trials as Topic*
  • Humans
  • Lipidomics* / methods
  • Phospholipids* / metabolism

Substances

  • Phospholipids
  • Biomarkers